Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-20 Purchase |
2020-10-20 8:01 pm |
Tarsus Pharmaceuticals Inc. | TARS | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N Heron Patrick J 10% Owner |
312,500 | $16 | $5,000,000 | 1,917,157 (Direct) |
View |
| 2020-10-20 Purchase |
2020-10-20 7:59 pm |
Tarsus Pharmaceuticals Inc. | TARS | Horowitz Limited Partnership VIII 10% Owner |
184,375 | $16 | $2,950,000 | 1,987,105 (Indirect Direct) |
View |
| 2020-10-20 Purchase |
2020-10-20 7:58 pm |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
250,000 | $16 | $4,000,000 | 3,245,035 (Direct) |
View |
| 2020-10-20 Purchase |
2020-10-20 7:56 pm |
Tarsus Pharmaceuticals Inc. | TARS | Tester Jason E. Director 10% Owner |
171,875 | $16 | $2,750,000 | 1,920,933 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-19 Option Award |
2020-11-23 7:00 pm |
N/A 2030-11-18 |
Tarsus Pharmaceuticals Inc. | TARS | YARNO WENDY L Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-10-26 2:39 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | RTW INVESTMENTS LP WONG RODERICK 10% Owner |
0 | $0 | 2,463,601 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-20 8:01 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N Heron Patrick J 10% Owner |
1,604,657 | $0 | 1,917,157 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:59 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Horowitz Limited Partnership VIII 10% Owner |
1,802,730 | $0 | 1,987,105 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:58 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
2,995,035 | $0 | 3,245,035 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:57 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
1,112,301 | $0 | 1,246,933 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:56 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Tester Jason E. Director 10% Owner |
1,777,456 | $0 | 1,920,933 (Indirect) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:54 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director 10% Owner |
63,185 | $0 | 1,228,924 (Direct) |
View |
| 2020-10-20 Conversion |
2020-10-20 7:53 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO 10% Owner |
23,325 | $0 | 1,235,021 (Indirect) |
View |
Ownership |
2020-10-15 8:27 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Frazier Life Sciences IX L.P. FHMLS IX L.P. FHMLS IX L.L.C. Topper James N Heron Patrick J 10% Owner |
0 | $0 | 1,604,657 (Direct) |
View |
Ownership |
2020-10-15 8:26 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Horowitz Limited Partnership VIII 10% Owner |
0 | $0 | 1,802,730 (Direct) |
View |
Ownership |
2020-10-15 8:24 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Vivo Capital IX LLC Vivo Capital Fund IX L.P. 10% Owner |
0 | $0 | 2,995,035 (Direct) |
View |
Ownership |
2020-10-15 8:23 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | LINK WILLIAM J PHD Director |
0 | $0 | 1,246,933 (Direct) |
View |
Ownership |
2020-10-15 8:22 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Tester Jason E. Director 10% Owner |
0 | $0 | 1,777,456 (Indirect) |
View |
Ownership |
2020-10-15 8:16 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director 10% Owner |
0 | $0 | 1,505,643 (Direct) |
View |
Ownership |
2020-10-15 8:14 pm |
N/A 2027-11-28 |
Tarsus Pharmaceuticals Inc. | TARS | Holdbrook Mark J. V.P., Clinical Affairs |
0 | $0 | 110,686 (Direct) |
View |
Ownership |
2020-10-15 8:13 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Mottiwala Aziz Chief Commercial Officer |
0 | $0 | 127,492 (Direct) |
View |
Ownership |
2020-10-15 8:11 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Neervannan Seshadri Chief Operating Officer |
0 | $0 | 276,749 (Direct) |
View |
Ownership |
2020-10-15 8:08 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Greenstein Leonard M. Chief Financial Officer |
0 | $0 | 166,030 (Direct) |
View |
Ownership |
2020-10-15 8:07 pm |
N/A N/A |
Tarsus Pharmaceuticals Inc. | TARS | Azamian Bobak R. President and CEO 10% Owner |
0 | $0 | 2,025,647 (Indirect) |
View |